Teijin Nakashima Medical

What Teijin Nakashima Medical does

NAKASHIMA HEALTHFORCE CO., LTD., referenced in the input as "Teijin Nakashima Medical," is a privately held Japanese medical device company headquartered in Akaiwa City, Okayama Prefecture (new HQ announced April 2026), specializing in the development, manufacture, and distribution of orthopedic implants — primarily artificial joints for the hip and knee. The firm employs 101-250 people and positions itself around lifelong-use artificial joints supported by three proprietary technology platforms: the Blend-E next-generation implant system, the UNIOS manufacturing methodology, and a custom-made medical technology program for patient-specific devices. Its product portfolio is marketed to healthcare providers performing joint replacement procedures, with distribution executed via direct-to-medical-institution sales supplemented by a dedicated B2B portal (formedic) for catalog and surgical technique materials and a patient-facing educational site (motto-kansetsu).

The company operates under ISO 13485 quality management for medical devices and received the Prime Minister's Award at the 10th Monozukuri Japan Awards in April 2026, recognizing its manufacturing and innovation profile in the orthopedic category. In May 2025 the firm completed a capital structure change and corporate name change, followed by a stock transfer in June 2025 — events consistent with a corporate restructuring/rebranding rather than a routine capital action. While the company claims a global market served footprint via its English-language site, its distribution channel is documented as single-country/domestic, indicating that international expansion is currently aspirational rather than operational.

Revenue mechanics are anchored in B2B implant sales to hospitals and orthopedic surgeons; pricing is not publicly disclosed. The broader market context is favorable: the global orthopedic devices market is forecast to grow from $58.56B in 2024 to $86.56B by 2033, the global spinal surgery devices and equipment market to $14.3B by 2030 (5.2% CAGR), and the global orthopedic appliances and fracture aids market to $32.30B by 2033 (4.7% CAGR). No management team, headcount trend, or named customer data is disclosed, and revenue is not publicly reported.

Name

Teijin Nakashima Medical

Legal name

NAKASHIMA HEALTHFORCE CO., LTD.

Website

https://teijin-nakashima.co.jp

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

NAKASHIMA HEALTHFORCE CO., LTD. (referenced as Teijin Nakashima Medical) is a privately held Japanese medical device manufacturer that develops, produces, and distributes orthopedic implants — primarily artificial hip and knee joints — with proprietary platforms including Blend-E, UNIOS, and custom-made patient-specific implant technology.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Orthopedic implants
• Artificial joints
• Medical device manufacturing
• Hip knee replacements
• Custom-made implants

Headquarters

HQ city

Okayama

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

Teijin Nakashima Medical develops, manufactures, and distributes orthopedic implants, with a flagship portfolio of artificial joints designed for lifelong use. The company produces hip and knee joint replacement implants, including next-generation products built on its proprietary Blend-E technology platform, and offers custom-made implants tailored to individual patient anatomy. Products are sold primarily to medical institutions and surgical teams in Japan.

Product overview

Nakashima Healthforce Co., Ltd. is a specialized medical device company focused on orthopedic implants. The core product line centers on orthopedic implants, with flagship artificial joint products designed for lifelong use. The portfolio includes hip and knee joint replacements, supported by custom-made medical technology enabling patient-specific implant solutions. The company employs advanced manufacturing technologies including the Blend-E system for next-generation artificial joints and the UNIOS innovation methodology. Products are developed, manufactured, and distributed as a unified implant business, with offerings accessible to medical professionals through dedicated product catalogs.

Differentiator

Problem solved

Functional benefit

Products and services

• Orthopedic Implants (整形外科インプラント) Core product line of orthopedic implants, including artificial joints for hip and knee replacement, developed and manufactured for medical institutions and orthopedic surgical teams.
• Artificial Joints (人工関節) - Blend-E Platform Artificial joint products designed for lifelong use, with development focused on the proprietary Blend-E technology platform for next-generation hip and knee implants. Targeted at medical institutions and orthopedic surgeons.
• Custom-Made Medical Technology (カスタムメイド医療技術) Personalized medical technology offering optimal treatment for individual patients through custom-designed orthopedic implants. Provided to medical institutions and surgical teams requiring patient-specific implant solutions.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Smith+Nephew: Established orthopedic reconstruction player focused on hip and knee implants. Direct competitor in arthroplasty with overlapping surgeon customer base.
• Stryker: Global orthopedic leader with strong knee and hip implant franchises plus surgical robotics. Comparable to Teijin Nakashima Medical in core artificial joint business, though at much larger scale and broader portfolio.
• DJO (Enovis): Orthopedic and rehabilitation medical device company with joint reconstruction products. Comparable product offering and customer base in arthroplasty.
• Zimmer Biomet: One of the world's largest orthopedic device companies with a flagship hip and knee arthroplasty portfolio. Directly comparable to Teijin Nakashima Medical in core product category (artificial joints) and target customer base (orthopedic surgeons and hospitals).
• Exactech: Orthopedic device company specializing in joint replacement implants and instrumentation. Mid-sized direct peer to Teijin Nakashima Medical in hip/knee arthroplasty.

Broad incumbents

• B. Braun: Large medical device company with an orthopedic / surgical implants division. Comparable as a broad incumbent selling implants and surgical supplies into hospitals.
• Johnson & Johnson (DePuy Synthes): Orthopedic and surgical device arm of a healthcare conglomerate. Overlaps with Teijin Nakashima Medical in hip/knee arthroplasty but operates as part of a much broader medical devices portfolio.

Emerging players

• ConforMIS: Specialist in patient-specific (custom-made) knee implants. Highly comparable to Teijin Nakashima Medical's custom-made medical technology positioning in arthroplasty.
• Corin: Orthopedic company focused on hip and knee implants with emphasis on innovative implant designs. Comparable emerging specialist in arthroplasty with similar scale and niche focus.

Regional players

• Kyocera (Medical): Japanese ceramics and medical device manufacturer with orthopedic implant offerings. Comparable regional peer competing in the Japan orthopedic market.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=100054617192658

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teijin Nakashima Medical